203 related articles for article (PubMed ID: 32945422)
1. Downregulated miR‑130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin.
Liu H; Liu M; Zhang J; Liang Y
Mol Med Rep; 2020 Oct; 22(4):2810-2816. PubMed ID: 32945422
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of microRNA let-7f mediated the Adriamycin resistance in leukemia cell line.
Cao YX; Wen F; Luo ZY; Long XX; Luo C; Liao P; Li JJ
J Cell Biochem; 2020 Oct; 121(10):4022-4033. PubMed ID: 31793054
[TBL] [Abstract][Full Text] [Related]
3. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p.
Sun H; Sun Y; Chen Q; Xu Z
Life Sci; 2020 Jan; 241():117161. PubMed ID: 31837329
[TBL] [Abstract][Full Text] [Related]
4. Curcumin attenuates Adriamycin-resistance of acute myeloid leukemia by inhibiting the lncRNA HOTAIR/miR-20a-5p/WT1 axis.
Liu JM; Li M; Luo W; Sun HB
Lab Invest; 2021 Oct; 101(10):1308-1317. PubMed ID: 34282279
[TBL] [Abstract][Full Text] [Related]
5. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2.
Li Q; Song W; Wang J
Biomed Pharmacother; 2019 Jan; 109():1793-1801. PubMed ID: 30551433
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1.
Wan L; Tian Y; Zhang R; Peng Z; Sun J; Zhang W
J Cell Biochem; 2018 May; 119(5):3843-3852. PubMed ID: 29058777
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/β-catenin pathway.
Kang Y; Zhang S; Cao W; Wan D; Sun L
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426817
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells.
Li Y; Guo Y; Feng Z; Bergan R; Li B; Qin Y; Zhao L; Zhang Z; Shi M
Nutr Cancer; 2019; 71(6):1007-1018. PubMed ID: 31032633
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
[TBL] [Abstract][Full Text] [Related]
11. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
Hu D; Li M; Su J; Miao K; Qiu X
Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
13. miR‑125a‑5p reverses epithelial‑mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer.
Li D; Chen L; Zhang X; Wang Y; Huang C; Li J; He F; He W
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34549308
[TBL] [Abstract][Full Text] [Related]
14. Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway.
Huang Q; Wu YY; Xing SJ; Yu ZW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5285-5292. PubMed ID: 31298380
[TBL] [Abstract][Full Text] [Related]
15. microRNA-146a Promotes Growth of Acute Leukemia Cells by Downregulating Ciliary Neurotrophic Factor Receptor and Activating JAK2/STAT3 Signaling.
Wang L; Zhang H; Lei D
Yonsei Med J; 2019 Oct; 60(10):924-934. PubMed ID: 31538427
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155.
Yu Y; Kou D; Liu B; Huang Y; Li S; Qi Y; Guo Y; Huang T; Qi X; Jia L
Int J Lab Hematol; 2020 Aug; 42(4):464-472. PubMed ID: 32359033
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
Lin M; Hu J; Liu T; Li J; Chen B; Chen X
Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
[TBL] [Abstract][Full Text] [Related]
18. HIF-1α forms regulatory loop with YAP to coordinate hypoxia-induced adriamycin resistance in acute myeloid leukemia cells.
Zhu B; Pan S; Liu J; Wang S; Ni Y; Xiao L; Wei Q; Peng Y; Ding Z; Zhao W
Cell Biol Int; 2020 Feb; 44(2):456-466. PubMed ID: 31617641
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.
Lin S; Yu L; Song X; Bi J; Jiang L; Wang Y; He M; Xiao Q; Sun M; Olopade OI; Zhao L; Wei M
Cell Death Dis; 2019 Sep; 10(9):666. PubMed ID: 31511498
[TBL] [Abstract][Full Text] [Related]
20. USP37 downregulation elevates the Chemical Sensitivity of Human Breast Cancer Cells to Adriamycin.
Qin T; Cui XY; Xiu H; Huang C; Sun ZN; Xu XM; Li LH; Yue L
Int J Med Sci; 2021; 18(2):325-334. PubMed ID: 33390801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
